Virios Therapeutics (VIRI) Scheduled to Post Quarterly Earnings on Thursday

Virios Therapeutics (NASDAQ:VIRI) is scheduled to release its earnings data before the market opens on Thursday, May 9th. Analysts expect Virios Therapeutics to post earnings of ($0.08) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Virios Therapeutics (NASDAQ:VIRI) last announced its quarterly earnings data on Thursday, February 29th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.03. On average, analysts expect Virios Therapeutics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Virios Therapeutics Price Performance

Shares of VIRI opened at $0.41 on Wednesday. Virios Therapeutics has a 1 year low of $0.28 and a 1 year high of $2.42. The stock’s fifty day moving average price is $0.42 and its two-hundred day moving average price is $0.52. The firm has a market cap of $7.95 million, a PE ratio of -1.48 and a beta of 1.87.

Virios Therapeutics Company Profile

Virios Therapeutics, Inc, a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.